ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 709,87
1,27%
DAX
18 001,60
0,54%
Brent Oil
83,105
-0,63%
Bitcoin
61 956,04
4,79%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Protalix BioTherapeutics Inc (PLX)

  7. Protalix BioTherapeutics Inc (PLX) Actualités

PLX

Protalix BioTherapeutics (PLX)

Protalix BioTherapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:PLX
DateHeureSourceTitreSymboleSociété
02/01/202412h36Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:PLXProtalix BioTherapeutics Inc
26/12/202312h56Edgar (US Regulatory)Form 8-K - Current reportAMEX:PLXProtalix BioTherapeutics Inc
30/11/202310h00GlobeNewswire Inc.Levicept Appoints Eliot Forster as CEOAMEX:PLXProtalix BioTherapeutics Inc
06/11/202313h50Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:PLXProtalix BioTherapeutics Inc
31/10/202321h40AllPennyStocks.comUpcoming Earnings Release Paired With Price Target Raise Sends Stock SoaringAMEX:PLXProtalix BioTherapeutics Inc
20/10/202312h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
15/09/202322h45Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:PLXProtalix BioTherapeutics Inc
06/09/202312h50PR Newswire (US)Protalix BioTherapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceAMEX:PLXProtalix BioTherapeutics Inc
11/08/202322h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:PLXProtalix BioTherapeutics Inc
07/07/202322h30Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:PLXProtalix BioTherapeutics Inc
29/06/202313h25Edgar (US Regulatory)Current Report Filing (8-k)AMEX:PLXProtalix BioTherapeutics Inc
28/06/202322h30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:PLXProtalix BioTherapeutics Inc
28/06/202322h30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:PLXProtalix BioTherapeutics Inc
18/05/202323h08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:PLXProtalix BioTherapeutics Inc
02/05/202314h27Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:PLXProtalix BioTherapeutics Inc
01/05/202312h48Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:PLXProtalix BioTherapeutics Inc
27/02/202313h59Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:PLXProtalix BioTherapeutics Inc
27/02/202312h47Edgar (US Regulatory)Annual Report (10-k)AMEX:PLXProtalix BioTherapeutics Inc
03/01/202312h04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:PLXProtalix BioTherapeutics Inc
14/11/202213h08Edgar (US Regulatory)Quarterly Report (10-q)AMEX:PLXProtalix BioTherapeutics Inc
09/09/202223h04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:PLXProtalix BioTherapeutics Inc
14/07/202222h32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:PLXProtalix BioTherapeutics Inc
05/07/202222h31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:PLXProtalix BioTherapeutics Inc
09/06/202220h53Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:PLXProtalix BioTherapeutics Inc
02/05/202212h26Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:PLXProtalix BioTherapeutics Inc
20/04/202222h50Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:PLXProtalix BioTherapeutics Inc
23/10/202023h02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)AMEX:PLXProtalix BioTherapeutics Inc
14/08/202023h03Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:PLXProtalix BioTherapeutics Inc
01/06/202023h22Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:PLXProtalix BioTherapeutics Inc
29/04/202023h13Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:PLXProtalix BioTherapeutics Inc
 Showing the most relevant articles for your search:AMEX:PLX

Dernières Valeurs Consultées

COIN
ETHUSD
Ethereum
EU
CS
Axa
EU
ORA
Orange
EU
PX1
CAC 40
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
EU
BN
Danone
SPI
SP500
S&P 500
EU
ML
Michelin
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
EU
PX4
SBF 120
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés